MannKind Corp (MNKD)
US$ 5.22-0.76%
Price Chart
Key Statistics
Market Cap
$ 1.25B
P/E Ratio
41.20
Revenue (TTM)
$ 297.6M
Volume
2.48M
52W High
$ 7.63
52W Low
$ 4.05
Dividend Yield
0.00%
Beta
1.14
Technicals
50-Day MA
4.7184
200-Day MA
5.8124
52 Week High
7.63
52 Week Low
4.05
About MNKD
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States. It.
Employees
403
Headquarters
Danbury, CT
CEO
Dr. Michael E. Castagna Pharm.D.
Latest News
MannKind: Why I'm Still Bullish Despite Tyvaso DPI Competition - Seeking Alpha
3 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg